China’s ‘COVID Success Story’ Might Not End Well

China’s ‘COVID Success Story’ Might Not End Well
A medical worker gives a coronavirus vaccine shot to a patient at a vaccination facility in Beijing, Jan. 15, 2021 (AP photo by Mark Schiefelbein).

Editor’s Note: This is the web version of our subscriber-only weekly newsletter, China Note, which includes a look at the week’s top stories and best reads from and about China. Subscribe to receive it by email every Wednesday. If you’re already a subscriber, adjust your newsletter settings to receive it directly to your email inbox.

After getting off to a slow start when it was launched in January, China’s vaccination campaign has picked up pace, hitting 1 billion total doses administered Saturday, according to the National Health Commission. It is well on track to meet its goal of vaccinating 40 percent of its 1.4 billion people by the end of June.

With the wind at its back, Beijing has wasted no time in championing its authoritarian approach as a model for others to follow. But new questions about the efficacy of Chinese vaccines and a recent outbreak in the southern province of Guangdong are casting fresh doubts on China’s COVID success story.

Keep reading for free

Already a subscriber? Log in here .

Get instant access to the rest of this article by creating a free account below. You'll also get access to three articles of your choice each month and our free newsletter:
Subscribe for an All-Access subscription to World Politics Review
  • Immediate and instant access to the full searchable library of tens of thousands of articles.
  • Daily articles with original analysis, written by leading topic experts, delivered to you every weekday.
  • The Daily Review email, with our take on the day’s most important news, the latest WPR analysis, what’s on our radar, and more.